Life Science Compliance Update

« Previous article | Home| Next article »

January 25, 2017

Not All Discounts Are Equal: Evaluating When Discounts May Be Construed as Unlawful


Discounts within the health care industry are historically viewed as not being subject to the U.S. Federal Anti-Kick Back Statutes (“AKS”). Recently, the U.S. Department of Justice (“DOJ”) and U.S. Courts have sought to clarify, refine, and otherwise limit the scope of the discount “safe harbor” provision, putting the life sciences and health industry on notice that not all discounts are necessarily immune from AKS violations. As a result, companies are no longer blindly able to rely on “safe harbor” protections and need to re-evaluate their discount programs.

The life sciences industry widely acknowledges that the federal anti-kickback statute (“AKS”) makes doing business with customers more challenging than for other sectors. This challenge is due in part to the fact that the law makes it illegal to “exchange (or offer to exchange), anything of value, in an effort to induce (or reward) the referral of federal health care program business."

Read the full article in the January 2017 issue of Life Science Compliance Update

To Read the Full Story, Subscribe, Download a Sample Issue, or Sign In

« Previous article | Home| Next article »


Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.


Preview | Powered by FeedBlitz


April 2018
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30